Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,912 | 88,952 | 43,231 | 31,063 | 40,608 |
| Marketable Securities | 55,722 | 11,997 | 25,983 | 39,950 | 41,692 |
| Receivables | 500 | N/A | N/A | N/A | N/A |
| TOTAL | $90,625 | $102,596 | $70,039 | $71,861 | $83,437 |
| Non-Current Assets | |||||
| PPE Net | 2,649 | 2,550 | 2,490 | 1,945 | 1,746 |
| Other Non-Current Assets | 146 | 146 | 146 | 146 | 146 |
| TOTAL | $2,795 | $2,696 | $2,636 | $2,091 | $1,892 |
| Total Assets | $93,420 | $105,292 | $72,675 | $73,952 | $85,329 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 758 | N/A | N/A | N/A | 7,620 |
| Accounts payable and accrued liabilities | 2,160 | 1,678 | 2,198 | 1,177 | 2,470 |
| Accrued Expenses | 7,440 | 7,254 | 5,413 | 4,769 | 4,699 |
| Other current liabilities | 125 | 12 | N/A | 1 | 3 |
| TOTAL | $12,588 | $11,049 | $9,716 | $8,052 | $16,897 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,069 | 14,808 | 14,789 | 6,676 | 1,081 |
| Deferred Revenues | 2,105 | 2,105 | 2,105 | 2,105 | 2,105 |
| Other Non-Current Liabilities | 1,570 | 1,522 | 1,171 | 2,235 | 1,190 |
| TOTAL | $15,837 | $17,054 | $17,210 | $10,687 | $4,574 |
| Total Liabilities | $28,425 | $28,103 | $26,926 | $18,739 | $21,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,858 | 52,769 | 41,686 | 41,416 | 41,401 |
| Common Shares | 53 | 53 | 41 | 41 | 41 |
| Retained earnings | -232,933 | -218,798 | -206,301 | -195,617 | -185,972 |
| Other shareholders' equity | -10 | 0 | -10 | -36 | -31 |
| TOTAL | $64,995 | $77,189 | $45,749 | $55,213 | $63,858 |
| Total Liabilities And Equity | $93,420 | $105,292 | $72,675 | $73,952 | $85,329 |